HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulatory effects of endogenous adenosine on epinephrine secretion from the adrenal medulla of the rat.

Abstract
The purpose of this study was to examine (1) whether endogenous adenosine receptors inhibit the release of epinephrine and norepinephrine from adrenal medulla in response to physiological and pharmacological stimuli and (2) whether the renin-angiotensin system modulates this effect of endogenous adenosine. We used a conscious animal model to approximate normal physiological conditions. Male Sprague-Dawley rats were treated with a surface adenosine receptor antagonist, 1,3-dipropyl- 8-(p-sulfophenyl)xanthine (DPSPX) to explore the effect of endogenous adenosine. Plasma epinephrine and norepinephrine levels in response to hydralazine-induced hypotension were measured in these animals. The same protocol was repeated in rats pretreated with either adrenalectomy or captopril. The results showed that DPSPX treatment significantly increased plasma epinephrine and norepinephrine levels at both baseline conditions and after hydralazine-induced hypotension. The results from the adrenalectomized rats showed that the difference in plasma epinephrine level between the control and DPSPX groups originated from the adrenal medulla. Pretreatment with captopril attenuated the rise of plasma epinephrine and norepinephrine levels in DPSPX-treated animals. This result suggests that endogenous adenosine receptors inhibit epinephrine release from the adrenal medulla and suppress plasma norepinephrine levels. When catecholamine release was stimulated by physiological and pharmacological stimuli, this inhibitory function of adenosine receptors was augmented. The renin-angiotensin system is at least partially responsible for the modulatory function of endogenous adenosine on the catecholamine response as demonstrated in this study.
AuthorsC J Tseng, W Y Ho, H C Lin, C S Tung, C J Kuan
JournalHypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 24 Issue 6 Pg. 714-8 (Dec 1994) ISSN: 0194-911X [Print] United States
PMID7995628 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Xanthines
  • Hydralazine
  • 1,3-dipropyl-8-(4-sulfophenyl)xanthine
  • Captopril
  • Adenosine
  • Norepinephrine
  • Epinephrine
Topics
  • Adenosine (physiology)
  • Adrenal Medulla (metabolism)
  • Animals
  • Captopril (pharmacology)
  • Epinephrine (blood, metabolism)
  • Hydralazine
  • Hypotension (chemically induced, metabolism)
  • Male
  • Norepinephrine (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Xanthines (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: